Log in | Register

What’s new in status epilepticus?

Andrea O. Rossetti| Thomas P. Bleck
What's New in Intensive Care
Volume 40, Issue 9 / September , 2014

Pages 1359 - 1362

No abstract available.

References

  1. Bleck TP (2005) Refractory status epilepticus. Curr Opin Crit Care 11:117–120
    • View reference on PubMed
    • View reference on publisher's website
  2. Rossetti AO, Lowenstein DH (2011) Management of refractory status epilepticus in adults: still more questions than answers. Lancet Neurol 10:922–930
    • View reference on PubMed
    • View reference on publisher's website
  3. Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, Laroche SM, Riviello JJ Jr, Shutter L, Sperling MR, Treiman DM, Vespa PM, Neurocritical Care Society Status Epilepticus Guideline Writing C (2012) Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 17:3–23
    • View reference on publisher's website
  4. Meierkord H, Boon P, Engelsen B, Gocke K, Shorvon S, Tinuper P, Holtkamp M (2010) EFNS guideline on the management of status epilepticus in adults. Eur J Neurol 17:348–355
    • View reference on PubMed
    • View reference on publisher's website
  5. Ferlisi M, Shorvon S (2012) The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy. Brain 135:2314–2328
    • View reference on PubMed
    • View reference on publisher's website
  6. Silbergleit R, Durkalski V, Lowenstein D, Conwit R, Pancioli A, Palesch Y, Barsan W (2012) Intramuscular versus intravenous therapy for prehospital status epilepticus. N Eng J Med 366:591–600
    • View reference on publisher's website
  7. Alvarez V, Januel JM, Burnand B, Rossetti AO (2011) Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam. Epilepsia 52:1292–1296
    • View reference on PubMed
    • View reference on publisher's website
  8. Yasiry Z, Shorvon SD (2014) The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: a meta-analysis of published studies. Seizure 23:167–174
    • View reference on PubMed
    • View reference on publisher's website
  9. Kellinghaus C, Berning S, Stogbauer F (2014) Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus. Acta Neurol Scand 129:294–299
  10. Bleck T, Cock H, Chamberlain J, Cloyd J, Connor J, Elm J, Fountain N, Jones E, Lowenstein D, Shinnar S, Silbergleit R, Treiman D, Trinka E, Kapur J (2013) The established status epilepticus trial 2013. Epilepsia 54[Suppl 6]:89–92
    • View reference on PubMed
    • View reference on publisher's website
  11. Rossetti AO, Milligan TA, Vulliemoz S, Michaelides C, Bertschi M, Lee JW (2011) A randomized trial for the treatment of refractory status epilepticus. Neurocrit Care 14:4–10
    • View reference on PubMed
    • View reference on publisher's website
  12. Gaspard N, Foreman B, Judd LM, Brenton JN, Nathan BR, McCoy BM, Al-Otaibi A, Kilbride R, Fernandez IS, Mendoza L, Samuel S, Zakaria A, Kalamangalam GP, Legros B, Szaflarski JP, Loddenkemper T, Hahn CD, Goodkin HP, Claassen J, Hirsch LJ, Laroche SM (2013) Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study. Epilepsia 54:1498–1503
    • View reference on PubMed
    • View reference on publisher's website
  13. Synowiec AS, Singh DS, Yenugadhati V, Valeriano JP, Schramke CJ, Kelly KM (2013) Ketamine use in the treatment of refractory status epilepticus. Epilepsy Res 105:183–188
    • View reference on PubMed
    • View reference on publisher's website
  14. Thakur KT, Probasco JC, Hocker SE, Roehl K, Henry B, Kossoff EH, Kaplan PW, Geocadin RG, Hartman AL, Venkatesan A, Cervenka MC (2014) Ketogenic diet for adults in super-refractory status epilepticus. Neurology 82:665–670
    • View reference on PubMed
    • View reference on publisher's website
  15. Ferguson M, Bianchi MT, Sutter R, Rosenthal ES, Cash SS, Kaplan PW, Westover MB (2013) Calculating the risk benefit equation for aggressive treatment of non-convulsive status epilepticus. Neurocrit Care 18:216–227
    • View reference on PubMed
    • View reference on publisher's website
  16. Rossetti AO, Alvarez V, Januel JM, Burnand B (2013) Treatment deviating from guidelines does not influence status epilepticus prognosis. J Neurol 260:421–428
    • View reference on PubMed
    • View reference on publisher's website
  17. Kowalski RG, Ziai WC, Rees RN, Werner JK Jr, Kim G, Goodwin H, Geocadin RG (2012) Third-line antiepileptic therapy and outcome in status epilepticus: the impact of vasopressor use and prolonged mechanical ventilation. Crit Care Med 40:2677–2684
    • View reference on PubMed
    • View reference on publisher's website
  18. Sutter R, Marsch S, Fuhr P, Kaplan PW, Ruegg S (2014) Anesthetic drugs in status epilepticus: risk or rescue?: A 6-year cohort study. Neurology 82:656–664
    • View reference on PubMed
    • View reference on publisher's website

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement